Dr. Michael Tymianski
Krembil Brain Institute researcher and Sprott Department of Surgery neurosurgeon, Dr. Michael Tymianski, has worked on developing nerinetide (NA-1) for two decades (Photo: The Globe and Mail)

It has been a year unlike any other at UHN as COVID-19 has impacted every aspect of our community. At UHN News, we’re looking back at some of our top stories over the past 12 months, from patient care, research and education amid the pandemic, to milestones and achievements in spite of it.


Share This Story

Share Tweet Email